These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6542016)

  • 21. Mitomycin C combination therapy against murine tumor systems. Effectiveness with cyclophosphamide and methotrexate.
    Mabel JA; Wodinsky I
    Cancer; 1983 Feb; 51(4):600-5. PubMed ID: 6401590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of the chemotherapeutic action of 5'-deoxy-5-fluorouridine in combination with guanosine and related compounds.
    Iigo M; Miwa M; Ishitsuka H; Nitta K
    Cancer Chemother Pharmacol; 1987; 19(1):61-4. PubMed ID: 3028664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-resistance of drug-resistant murine leukemias to deoxyspergualin (NSC 356894) in vivo.
    Harrison SD; Brockman RW; Trader MW; Laster WR; Griswold DP
    Invest New Drugs; 1987 Dec; 5(4):345-51. PubMed ID: 3436739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined effects of bromovinyldeoxyuridine and fractionated or continuous administration of 5-fluorouracil in P388 leukemia-bearing mice.
    Keizer HJ; Pauwels R; Landuyt W; Balzarini J; van der Schueren E; De Clercq E
    Cancer Lett; 1988 Mar; 39(2):217-23. PubMed ID: 3359416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of 2,3-dihydro-1 H-imidazo[1,2-b]pyrazole on the proliferation of mouse leukemic and normal cells in vivo.
    Ganapathi R; Krishan A
    Cancer Res; 1980 Apr; 40(4):1103-8. PubMed ID: 7357541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response of transplantable tumors in mice and of macromolecular synthesis to 17 beta-acetamido-3-aza-A-homo-4 alpha-androsten-4-one.
    Athanasiou C; Catsoulacos P; Papageorgiou A; Athanasiou K
    Cancer Invest; 1987; 5(4):301-7. PubMed ID: 3664333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of thymidine on the toxicity and antitumor activity of ftorafur.
    Grossie VB; Loo TL
    Cancer Treat Rep; 1981; 65(11-12):1087-91. PubMed ID: 6794908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of methotrexate inhibition of colony growth of L1210 leukemia cells in semisolid medium.
    Nederbragt H; Uitendaal MP; van der Grint L; Leyva A; Pinedo HM
    Cancer Res; 1981 Mar; 41(3):1193-8. PubMed ID: 6970074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of the anthracycline agent, 7-con-O-methylnogarol (7-OMEN), administered orally to mice bearing P388 or L1210 leukemia.
    McGovren JP
    Cancer Treat Rep; 1980; 64(4-5):727-9. PubMed ID: 6448690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experimental combination chemotherapy of YNK01, a novel analog of cytarabine, with other antitumor agents].
    Uchida T; Nagahata T; Arakawa M; Ekimoto H; Takahashi K
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1351-6. PubMed ID: 2114829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388.
    Avramis VI; Plunkett W
    Cancer Res; 1982 Jul; 42(7):2587-91. PubMed ID: 7083151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.
    Li LH; Wallace TL; Richard KA; Tracey DE
    Cancer Res; 1985 Feb; 45(2):532-8. PubMed ID: 3967227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor activity of spergualin, a novel antitumor antibiotic.
    Nishikawa K; Shibasaki C; Takahashi K; Nakamura T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1986 Oct; 39(10):1461-6. PubMed ID: 3781914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of supplemental ascorbate on the antitumor activity of 5-hydroxydopa, a purported cytotoxic metabolite.
    Pierson HF; Meadows GG
    Cancer Lett; 1985 Nov; 29(2):157-68. PubMed ID: 3935310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative biochemical aspects of low and high doses of methotrexate in mice.
    Zaharko DS; Fung WP; Yang KH
    Cancer Res; 1977 Jun; 37(6):1602-7. PubMed ID: 870175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergy between 5,10-dideaza-5,6,7,8-tetrahydrofolic acid and methotrexate in mice bearing L1210 tumors.
    Ferguson K; Boschelli D; Hoffman P; Oronsky A; Whiteley J; Webber S; Galivan J; Freishiem J; Hynes J; Kerwar SS
    Cancer Chemother Pharmacol; 1989; 25(3):173-6. PubMed ID: 2598407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diminished toxicity of methotrexate in CD2F1 mice pretreated with cycloheximide.
    Panasci L; Polizzi G; Palmer S
    Cancer Lett; 1982 Jan; 15(1):81-6. PubMed ID: 7059964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation by taurine of the toxicity of taumustine, a compound with antitumor activity.
    Pierson HF; Fisher JM; Rabinovitz M
    J Natl Cancer Inst; 1985 Nov; 75(5):905-9. PubMed ID: 3863989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic synergism of tiazofurin and selected antitumor drugs against sensitive and resistant P388 leukemia in mice.
    Harrison SD; O'Dwyer PJ; Trader MW
    Cancer Res; 1986 Jul; 46(7):3396-400. PubMed ID: 3708573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of high-dose methotrexate with leucovorin rescue therapy in the L1210 leukemia and sarcoma 180 murine tumor models.
    Sirotnak FM; Moccio DM; Dorick DM
    Cancer Res; 1978 Feb; 38(2):345-53. PubMed ID: 304375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.